NASDAQ MDCO

Related by string. Nasdaq MDCO * NASDAQ. . nasdaq . Nasdaq : Inc. NASDAQ SCOR . NASDAQ OMX Group . Nasdaq Listing Qualifications . Apple Nasdaq AAPL . Motion RIM NASDAQ RIMM . NASDAQ . Motion RIM Nasdaq RIMM . Cisco Systems NASDAQ CSCO . NASDAQ COST . NASDAQ OMX indexes . NASDAQ OMX Nordic . Apple NASDAQ AAPL . NASDAQ OMX Riga / : Company NASDAQ MDCO . MDCO . Co. MDCO . Co MDCO * Co NASDAQ MDCO *

Related by context. Frequent words. (Click for all words.) 59 Inc Therapeutic Competitors 58 Generic Version 57 Company Nasdaq PRGO 56 OPTR 56 HITK 56 Nektar Therapeutics NKTR 56 NYSE SGP 56 CADX 56 Cholesterol Drug 56 Presents Positive 56 PROFILE CO 55 VRUS 55 Sciele Pharma Inc. 55 Q2 Profit Surges 55 Q4 Profit Surges 55 Co. NYSE BMY 54 IPXL 54 Shire Plc 54 Par Pharmaceuticals 54 Q1 Loss Narrows 54 DVAX 54 NYSE PFE 54 Cephalon CEPH 54 Colazal 54 Genelabs Technologies Inc. 53 Teva Pharmaceutical TEVA 53 Report companiesandmarkets.com adds 53 Calls Purchased 53 Barrier Therapeutics Inc. 53 Inc. NASDAQ SNTS 53 Q1 Loss Widens 53 Welcomes Analyst 53 Paladin Labs 53 ZGEN 53 FDA Clears 52 Bearish Pressure Building 52 CEO Exercises Options 52 Q3 Loss Narrows 52 Q4 Loss Narrows 52 Inc. Nasdaq IMGN 52 Bearish Technical 52 Drugmaker 52 Blood Thinner 52 SEPR 52 Bristol Myers NYSE BMY 52 Q3 Loss Widens 52 Teva Pharma 52 Progenics Pharmaceuticals Inc. 52 AUXL 52 Options Trader Alert 52 Inc. NASDAQ ALKS 52 quotes/comstock/# * 52 Drug Candidate 52 Onyx Pharmaceuticals 52 China Aoxing Pharmaceutical 52 Optimer Pharmaceuticals 52 NYSE MYL 52 Questcor Pharmaceuticals Inc. 51 Abbott ABT 51 Beats Analyst 51 Rebetol 51 Q2 Loss Narrows 51 Adeona Pharmaceuticals Inc. 51 Halozyme Therapeutics Inc. 51 Vytorin combines 51 Casodex 51 Nasdaq BIIB 51 Vanda Pharmaceuticals Inc. 51 1Q Profit Rises 51 Q4 Loss Widens 51 Q2 Profit Declines 51 AKRX 51 Diet Pill 51 Earnings Scorecard 51 Stock Downgraded 51 Inc. Nasdaq MYL 51 Interesting Options Volume 51 Targanta Therapeutics 51 Biopharm 51 MNTA 51 ISPH 51 Q3 Profit Surges 51 Pulmonary Arterial Hypertension 51 Q2 Profit Rises 51 Downgrade Alert Watch 51 Vertex Pharmaceuticals VRTX 51 Hold Third Quarter 51 Q2 Loss Widens 50 Completes Tender Offer 50 Movers roundup 50 Adcirca 50 Mylan Labs 50 GuruFocus rated 50 Gilead Sciences GILD 50 Ixempra 50 Medicines 50 Trend Continues Down 50 Diflucan 50 Drug Makers 50 Antipsychotic 50 DepoMed

Back to home page